CB
Clínica Baviera, S.A.
CBAV.MC · BME
57.00 € +0.35% (+0.20 €)
1M -6.56%
Market Cap 923.1M €
P/E Ratio 19.92x
Div. Yield 2.72%
ROE 41.91%
Bulios Fair Price
57.61 €
1.1% upside
Current Price
57 €
Undervalued Fair Value Overvalued
According to Bulios Fair Price, CBAV.MC is currently trading close to its fair value. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
58 /100
Fair P/E 19.92x
EV/EBITDA 10.07x
PEG 3.16x
Growth
74 /100
Growing EPS growth 12.54%
Rev. growth 15.00%
Book val. growth 17.76%
Profitability
89 /100
Strong Gross margin 82.14%
Net margin 14.62%
FCF margin 15.29%
Quality
100 /100
Excellent ROIC 24.46%
ROE 41.91%
Asset turnover 1.24x
Debt
90 /100
Low Debt/Equity 0.09x
Current ratio 0.94x
Net debt/EBITDA -0.00x
Stability
100 /100
Stable Beta 0.73x
Rev. volatility 1.72%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CBAV.MC
Online
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Eduardo Baviera Sabater
Employees
2,009
Headquarters
Madrid
Upcoming events
18 NOV
Earnings
Upcoming earnings report